Which aspect most directly ensures the scientific integrity and credibility of a clinical trial's data?

Prepare for the ICH Good Clinical Practice (GCP) Exam for Certified Clinical Research Coordinator with engaging multiple-choice questions and detailed explanations. Elevate your understanding and expertise to excel in your certification exam!

Multiple Choice

Which aspect most directly ensures the scientific integrity and credibility of a clinical trial's data?

Explanation:
A well-constructed trial design directly safeguards data integrity by defining how data are collected, controlled, and analyzed. It establishes key elements like randomization to reduce selection bias, control groups to provide a meaningful comparison, blinding to minimize measurement bias, and a pre-specified statistical analysis plan to prevent data-driven conclusions. It also sets the endpoints, timing, and follow-up procedures in a standardized way, ensuring consistency across sites and researchers. When these design components are robust, they create a reliable framework that yields valid, credible results that are interpretable and reproducible. Endpoint selection matters for what is measured and the trial’s ability to answer the question, but it sits within the design framework and does not inherently ensure data integrity on its own. Sponsor requirements and site selection influence governance and conduct, respectively, but their impact is indirect compared with the foundational role of the trial’s design in protecting data quality.

A well-constructed trial design directly safeguards data integrity by defining how data are collected, controlled, and analyzed. It establishes key elements like randomization to reduce selection bias, control groups to provide a meaningful comparison, blinding to minimize measurement bias, and a pre-specified statistical analysis plan to prevent data-driven conclusions. It also sets the endpoints, timing, and follow-up procedures in a standardized way, ensuring consistency across sites and researchers. When these design components are robust, they create a reliable framework that yields valid, credible results that are interpretable and reproducible.

Endpoint selection matters for what is measured and the trial’s ability to answer the question, but it sits within the design framework and does not inherently ensure data integrity on its own. Sponsor requirements and site selection influence governance and conduct, respectively, but their impact is indirect compared with the foundational role of the trial’s design in protecting data quality.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy